A mild, self-resolving case of Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis. (Record no. 308)

MARC details
000 -LEADER
fixed length control field 02444nam a22003977a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221018s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2214-2509
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.idcr.2022.e01616 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC9472058 [pmc]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S2214-2509(22)00244-X [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 36119758
245 ## - TITLE STATEMENT
Title A mild, self-resolving case of Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis.
251 ## - Source
Source IDCases. 30:e01616, 2022.
252 ## - Abbreviated Source
Abbreviated source IDCases. 30:e01616, 2022.
253 ## - Journal Name
Journal name IDCases
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Medline status PubMed-not-MEDLINE
266 ## - Date added to catalog
Date added to catalog 2022-10-20
520 ## - SUMMARY, ETC.
Abstract Hemophagocytic lymphohistiocytosis (HLH) is a multisystem disease caused by an excessive activation of the immune system. In most instances, HLH can be fatal without treatment; a life-threatening syndrome driven by a dysregulated immune system and activation of macrophages resulting in cytokine release and consequent cellular damage. HLH can occur as a consequence of multiple genetic abnormalities or environmental triggers. We present an interesting case of mild, self-resolving, HLH due to Epstein-Barr Virus (EBV) infection in a young woman. The best-known diagnostic criteria are based on the HLH-2004 trial, incorporating either the presence of known mutations or five of eight clinical and laboratory findings. Prompt initiation of etoposide-containing therapy is associated with improved survival. Rituximab, an anti-CD20 antibody, can also remove EBV-harboring B-cells and improve outcomes. In a rare subset of patients, the disease can spontaneously resolve without any therapeutic interventions thus sparing the patients from toxic therapies. Copyright © 2022 The Authors.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Franklin Square Medical Center
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Union Memorial Hospital
656 ## - INDEX TERM--OCCUPATION
Department Hospitalist
656 ## - INDEX TERM--OCCUPATION
Department Internal Medicine Residency
657 ## - INDEX TERM--FUNCTION
Medline publication type Case Reports
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Adhikari, Biplov
Institution Code MUMH
Program Internal Medicine Residency
Degree MBBS
Resident year Resident PGY 2
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Haas, Christopher
Institution Code MUMH
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Rao, Shiavax
Institution Code MUMH
Program Internal Medicine Residency
Degree MD
Resident year Resident PGY 3
790 ## - Authors
All authors Adhikari B, Haas CJ, Rao SJ
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1016/j.idcr.2022.e01616">https://dx.doi.org/10.1016/j.idcr.2022.e01616</a>
Public note https://dx.doi.org/10.1016/j.idcr.2022.e01616
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 10/20/2022   36119758 36119758 10/20/2022 10/20/2022 Journal Article

Powered by Koha